Leslie Popplewell

8PUBLICATIONS
46CO-AUTHORS
Psychology of ageingHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 09, 2024
Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update.

Martin Dreyling, Nathan Hale Fowler, Michael Dickinson

|Jun 20, 2023
Pembrolizumab plus vorinostat induces responses in patients with Hodgkin lymphoma refractory to prior PD-1 blockade.

Matthew Mei, Lu Chen, James Godfrey

|Apr 04, 2023
Adding venetoclax to lenalidomide and rituximab is safe and effective in patients with untreated mantle cell lymphoma.

Tycel J Phillips, David Bond, Radihka Takiar

|Aug 01, 2022
Cost-effectiveness of second-line axicabtagene ciloleucel in relapsed refractory diffuse large B-cell lymphoma.

Swetha Kambhampati Thiruvengadam, Monica Saumoy, Yecheskel Schneider

|Jun 14, 2022
Cost-effectiveness of polatuzumab vedotin combined with chemoimmunotherapy in untreated diffuse large B-cell lymphoma.

Swetha Kambhampati Thiruvengadam, Monica Saumoy, Yecheskel Schneider

|Jan 08, 2021
Double-hit Signature with TP53 Abnormalities Predicts Poor Survival in Patients with Germinal Center Type Diffuse Large B-cell Lymphoma Treated with R-CHOP.

Joo Y Song, Anamarija M Perry, Alex F Herrera

Pageof 2

Frequent Collaborators

4 joint publications

Alex F Herrera

3 joint publications

Tanya Siddiqi

2 joint publications

Lihua Elizabeth Budde

1 joint publications

Daniel O Persky